SCHEMBL21924136

SCHEMBL21924136

CC(I)c1ccc(CN2CCOCC2)cc1F

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.49
HRH3 Q9Y5N1 4/20 0.47
HTT P42858 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
NCF1 P14598 1/20 0.44
ALDH1A1 P00352 2/20 0.44
PDE4B Q07343 1/20 0.44
CYP2A13 Q16696 1/20 0.43
NPC1 O15118 2/20 0.43
TP53 P04637 2/20 0.43
TSHR P16473 2/20 0.43
RAB9A P51151 2/20 0.43
MAPK1 P28482 1/20 0.43
SIGMAR1 Q99720 1/20 0.41
NOS1 P29475 2/20 0.41
BRD4 O60885 1/20 0.41
CCL2 P13500 1/20 0.41
HPGD P15428 2/20 0.41
NOS3 P29474 1/20 0.41
NOS2 P35228 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21925208 0.89 MAPT (0.58) MAPTHRH3HTTSMN1; SMN2NCF1
SCHEMBL19542004 0.80 MAPT (0.62) MAPTHRH3HTTSMN1; SMN2NCF1
SCHEMBL8257960 0.78 HRH3 (0.54) HRH3HTTSMN1; SMN2NCF1ALDH1A1
SCHEMBL31082081 0.75 HRH3 (0.51) MAPTHRH3HTTSMN1; SMN2NCF1
SCHEMBL26351809 0.75 HRH3 (0.47) HRH3HTTSMN1; SMN2NCF1ALDH1A1
SCHEMBL23235186 0.75 HRH3 (0.54) MAPTHRH3HTTSMN1; SMN2NCF1
SCHEMBL17724130 0.75 HRH3 (0.54) HRH3HTTSMN1; SMN2NCF1ALDH1A1
SCHEMBL18491483 0.75 HRH3 (0.54) MAPTHRH3HTTSMN1; SMN2NCF1
SCHEMBL538318 0.75 HTT (0.58) MAPTHRH3HTTSMN1; SMN2NCF1
SCHEMBL632550 0.75 HRH3 (0.59) HRH3HTTSMN1; SMN2NCF1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3643709-A1 ISOINDOLINE DERIVATIVE, INTERMEDIATE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USE THEREOF Kangpu Biopharmaceuticals, Ltd. (CN) 2020-04-29 EP disclosed